Cargando…

Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C

BACKGROUND: Anesthesia and surgery can induce perioperative neurocognitive disorders (PND). Mitochondrial dysfunction has been proposed to be one of the earliest triggering events in surgery-induced neuronal damage. Dexmedetomidine has been demonstrated to attenuate the impairment of cognition in ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lina, Niu, Kun, Guo, Jian, Tu, Jingru, Ma, Baofeng, An, Jianxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026454/
https://www.ncbi.nlm.nih.gov/pubmed/36941579
http://dx.doi.org/10.1186/s12871-023-02035-x
_version_ 1784909544332197888
author Sun, Lina
Niu, Kun
Guo, Jian
Tu, Jingru
Ma, Baofeng
An, Jianxiong
author_facet Sun, Lina
Niu, Kun
Guo, Jian
Tu, Jingru
Ma, Baofeng
An, Jianxiong
author_sort Sun, Lina
collection PubMed
description BACKGROUND: Anesthesia and surgery can induce perioperative neurocognitive disorders (PND). Mitochondrial dysfunction has been proposed to be one of the earliest triggering events in surgery-induced neuronal damage. Dexmedetomidine has been demonstrated to attenuate the impairment of cognition in aged rats induced by surgery in our previous study. METHODS: Male Sprague-Dawley rats underwent hepatic apex resection under anesthesia with propofol to clinically mimic human abdominal surgery. The rats were divided into three groups: Control group, Model group and Dexmedetomidine (Dex) group. Cognitive function was evaluated with the Morris water maze (MWM), Open Field Test (OFT)and Novel object recognition task (NOR). Ultrastructural change in neuronal mitochondria was measured by transmission electron microscopy. Mitochondrial function was measured by mitochondrial membrane potential and activities of mitochondrial complexes. Neuronal morphology was observed with H&E staining and the activation of glial cells was observed by immunohistochemistry in the hippocampus. Protein levels were measured by Western blot (WB) and immunofluorescence at 3 and 7 days after surgery. RESULTS: Surgery-induced cognitive decline lasts three days, but not seven days after surgery in the model group. Transmission electron microscope showed the mitochondrial structure damage in the model group, similar changes were not induced in the Dex group. Dexmedetomidine may reverse the decrease in mitochondrial membrane potential and mitochondrial complex activity. Compared with the Control group, the expression of cytochrome c was significantly increased in model group by Western blot and immunofluorescence on days 3, but not day 7. Rats from the Model group expressed significantly greater levels of Iba-1 and GFAP compared with the Control group and the Dex group. CONCLUSION: Dexmedetomidine appears to reverse surgery-induced behavior, mitigate the higher density of Iba-1 and GFAP, reduce the damage of mitochondrial structure and function by alleviating oxidative stress and protect mitochondrial respiratory chain, thus increasing cytochrome c oxidase (COX) expression and downregulate the expression of cytochrome c protein in the hippocampus of rats. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-023-02035-x.
format Online
Article
Text
id pubmed-10026454
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100264542023-03-21 Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C Sun, Lina Niu, Kun Guo, Jian Tu, Jingru Ma, Baofeng An, Jianxiong BMC Anesthesiol Research BACKGROUND: Anesthesia and surgery can induce perioperative neurocognitive disorders (PND). Mitochondrial dysfunction has been proposed to be one of the earliest triggering events in surgery-induced neuronal damage. Dexmedetomidine has been demonstrated to attenuate the impairment of cognition in aged rats induced by surgery in our previous study. METHODS: Male Sprague-Dawley rats underwent hepatic apex resection under anesthesia with propofol to clinically mimic human abdominal surgery. The rats were divided into three groups: Control group, Model group and Dexmedetomidine (Dex) group. Cognitive function was evaluated with the Morris water maze (MWM), Open Field Test (OFT)and Novel object recognition task (NOR). Ultrastructural change in neuronal mitochondria was measured by transmission electron microscopy. Mitochondrial function was measured by mitochondrial membrane potential and activities of mitochondrial complexes. Neuronal morphology was observed with H&E staining and the activation of glial cells was observed by immunohistochemistry in the hippocampus. Protein levels were measured by Western blot (WB) and immunofluorescence at 3 and 7 days after surgery. RESULTS: Surgery-induced cognitive decline lasts three days, but not seven days after surgery in the model group. Transmission electron microscope showed the mitochondrial structure damage in the model group, similar changes were not induced in the Dex group. Dexmedetomidine may reverse the decrease in mitochondrial membrane potential and mitochondrial complex activity. Compared with the Control group, the expression of cytochrome c was significantly increased in model group by Western blot and immunofluorescence on days 3, but not day 7. Rats from the Model group expressed significantly greater levels of Iba-1 and GFAP compared with the Control group and the Dex group. CONCLUSION: Dexmedetomidine appears to reverse surgery-induced behavior, mitigate the higher density of Iba-1 and GFAP, reduce the damage of mitochondrial structure and function by alleviating oxidative stress and protect mitochondrial respiratory chain, thus increasing cytochrome c oxidase (COX) expression and downregulate the expression of cytochrome c protein in the hippocampus of rats. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-023-02035-x. BioMed Central 2023-03-20 /pmc/articles/PMC10026454/ /pubmed/36941579 http://dx.doi.org/10.1186/s12871-023-02035-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sun, Lina
Niu, Kun
Guo, Jian
Tu, Jingru
Ma, Baofeng
An, Jianxiong
Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title_full Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title_fullStr Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title_full_unstemmed Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title_short Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C
title_sort dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome c
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026454/
https://www.ncbi.nlm.nih.gov/pubmed/36941579
http://dx.doi.org/10.1186/s12871-023-02035-x
work_keys_str_mv AT sunlina dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec
AT niukun dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec
AT guojian dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec
AT tujingru dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec
AT mabaofeng dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec
AT anjianxiong dexmedetomidineattenuatespostoperativespatialmemoryimpairmentaftersurgerybyreducingcytochromec